Clinical Efficacy and Safety of Ranibizumab Versus Dexamethasone for Central Retinal Vein Occlusion (COMRADE C): A European Label StudyHans Hoerauf, Lars‐Olof Hattenbach, Claudia Weiß et al.|American Journal of Ophthalmology|2016Cited by 89
Impairment of the Retinal Endothelial Cell Barrier Induced by Long-Term Treatment with VEGF-A165 No Longer Depends on the Growth Factor’s PresenceHeidrun L. Deissler, Armin Wolf|Biomolecules|2022Cited by 5